Good Documentation Practices (GDP) in Pharmaceuticals: Rules, Examples, and Common Mistakes

Introduction

In the pharmaceutical industry, documentation is just as important as manufacturing. A product may be perfectly made, but if the documentation is incomplete or incorrect, the batch can be rejected. This is why Good Documentation Practices (GDP) are a fundamental part of GMP.

There is a well-known saying in pharma:

“If it is not documented, it did not happen.”

From real-world industry experience, many audit observations are related not to technical failures, but to documentation errors, such as missing signatures, overwriting, or incomplete records.

---

What is Good Documentation Practice (GDP)?

Good Documentation Practices (GDP)are guidelines that ensure all records are:

• Accurate
• Complete
• Legible
• Traceable
• Timely

GDP applies to all types of documents, including:

• Batch Manufacturing Records (BMR)
• Logbooks
• SOPs
• Test records
• Cleaning records

---

These records are critical during tablet manufacturing operations to ensure traceability and compliance.

Why GDP is Important

1. Ensures Traceability

Every action in pharma must be traceable — who did it, when, and how.

2. Prevents Data Manipulation

Proper documentation prevents falsification and ensures data integrity.

3. Supports Investigations

If a deviation occurs, records help identify the root cause.

4. Required by Regulatory Authorities

FDA, WHO, and other agencies strictly check documentation during inspections.

---

Basic Rules of Good Documentation Practices (GDP)

1. Write Clearly and Legibly

Entries must be readable. Illegible handwriting is a common audit finding.

2. Use Permanent Ink

Only a blue or black pen is allowed. Pencil or erasable ink is prohibited.

3. Record Data Immediately

Do not fill records later from memory. Entries must be made at the time of activity.

Backdated entries are a serious GMP violation.

4. Do Not Leave Blank Spaces

Blank fields should be marked as “N/A” (Not Applicable).

5. Corrections Must Be Proper

If a mistake is made:

• Draw a single line through the error
• Write the correct entry
• Sign and date the correction
• Give a reason if required

Never use correction fluid or scratch out entries.

Common Documentation Mistakes in Pharmaceuticals

Even trained staff sometimes make documentation errors. These mistakes can lead to batch rejection, regulatory observations, or even product recalls. Below are some of the most common GDP mistakes seen during inspections:

1. Using a pencil or Erasable Ink
All GMP records must be written in permanent ink. Pencil entries can be altered and are not acceptable.

2. Backdating or Postdating Entries
Recording information at a later time and entering an earlier date is a serious violation. Documentation must be done in real time.

3. Blank Spaces Left in Records
Empty fields create the risk of data manipulation. If a section is not applicable, write “N/A” and sign.

4. Overwriting Without Proper Correction
If a mistake is made, never scratch or use correction fluid. Draw a single line through the error, write the correct entry, sign, and date.

5. Missing Signatures or Dates
Every GMP activity must be traceable to a person and time. Missing signatures are one of the most frequent inspection observations.

---

Real Example of GDP Error

Imagine a production operator records the temperature of a granulation process two hours after completing the step. Even if the temperature was correct, this is still a GDP violation because the entry was not made at the time of activity.

During an audit, this can raise doubts about the reliability of the entire batch record.

This shows why “If it’s not documented, it didn’t happen” is taken seriously in pharmaceuticals.

---

How Good Documentation Practices (GDP) Support GMP Compliance

GDP is not just about writing neatly. It plays a direct role in maintaining product quality and patient safety.

✔ Ensures Traceability
Every action can be traced back to a person, time, and process step.

✔ Supports Investigations
When deviations occur, accurate documentation helps identify the root cause.

✔ Prevents Data Manipulation
Clear, permanent records protect data integrity.

✔ Required by Regulatory Authorities
USFDA, WHO, MHRA, and other agencies strictly check documentation during inspections.

Without proper GDP, even a perfectly manufactured product may be rejected.

---

Key Takeaway

Good Documentation Practices (GDP) are the backbone of pharmaceutical GMP. They ensure that every manufacturing, testing, and quality activity is recorded clearly, accurately, and in real time.

Strong GDP protects the company, supports compliance, and most importantly, ensures that patients receive safe and effective medicines.

---

ALCOA Principles of Data Integrity

GDP follows ALCOA principles:

• A – Attributable (Who did it?)
• L – Legible (Can it be read?)
• C – Contemporaneous (Recorded on time?)
• O – Original (First record?)
• A – Accurate (Correct data?)

Many companies now follow ALCOA+, adding:

• Complete
• Consistent
• Enduring
• Available

---

Good Documentation Practices (GDP) in Different Departments

In Production

• Recording process parameters
• In-process test results
• Equipment usage logs

Skipping entries during busy production shifts is a common issue in real life.

In Warehouse

• Material receipt entries
• Temperature logs
• Material issue records

Temperature logs with missing dates or signatures are frequent audit observations. Warehouse documentation, such as temperature records, must be maintained as part of pharmaceutical warehouse documentation practices.

In Quality Control

• Analytical test results
• Instrument logbooks
• Standard preparation records

---

Common Documentation Errors Seen in Pharma

Based on practical industry observations:

• Overwriting without a signature
• Missing dates
• Recording data after activity completion
• Using whitener/correction fluid
• Blank spaces left in records
• Mismatch between actual activity and recorded time

These small mistakes can lead to major audit observations.

---

Best Practices to Improve Good Documentation Practices (GDP) Compliance

• Train employees regularly on GDP
• Review records daily
• Use checklists
• Encourage error reporting instead of hiding mistakes

A strong documentation culture shows a strong GMP culture.

WHO documentation and GMP requirements

FDA current Good Manufacturing Practice (cGMP) regulations

---

Conclusion

Good Documentation Practices (GDP)are not just paperwork rules — they are essential to ensure transparency, traceability, and patient safety. Proper documentation proves that medicines are made correctly and safely.

In real pharmaceutical operations, strong GDP compliance often makes the difference between a smooth audit and a serious regulatory warning.